Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34895479

Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2022 Jan
First author
Mauz-Körholz C

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2022 Jan;23(1):11-13. doi: 10.1016/S1470-2045(21)00544-1.
    note
    Source null
    related pmid
    34895480
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2022 Feb;23(2):e59. doi: 10.1016/S1470-2045(22)00029-8.
    note
    Source null
    related pmid
    35114129
    relationship
    Erratum in
  3. citation
    Strahlenther Onkol. 2022 Jun;198(6):593-594. doi: 10.1007/s00066-022-01923-4.
    note
    Source null
    related pmid
    35364689
    relationship
    Comment in

Authors and identifiers

  1. name
    Mauz-Körholz C
    type
    Author
  2. name
    Landman-Parker J
    type
    Author
  3. name
    Balwierz W
    type
    Author
  4. name
    Ammann RA
    type
    Author
  5. name
    Anderson RA
    type
    Author
  6. name
    Attarbaschi A
    type
    Author
  7. name
    Bartelt JM
    type
    Author
  8. name
    Beishuizen A
    type
    Author
  9. name
    Boudjemaa S
    type
    Author
  10. name
    Cepelova M
    type
    Author
  11. name
    Claviez A
    type
    Author
  12. name
    Daw S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mauz-Körholz C
    type
    Author
  2. name
    Landman-Parker J
    type
    Author
  3. name
    Balwierz W
    type
    Author
  4. name
    Ammann RA
    type
    Author
  5. name
    Anderson RA
    type
    Author
  6. name
    Attarbaschi A
    type
    Author
  7. name
    Bartelt JM
    type
    Author
  8. name
    Beishuizen A
    type
    Author
  9. name
    Boudjemaa S
    type
    Author
  10. name
    Cepelova M
    type
    Author
  11. name
    Claviez A
    type
    Author
  12. name
    Daw S
    type
    Author
bibliography ids
  1. nci-bib-8fac28ea528ee6c23849316b
book metadata
content sha256
c2ce193b8d6b2d8b10ba310dfc5bf06313ea15bc3790a474af701dc472865964
document type
citation
dois
  1. 10.1016/S1470-2045(21)00470-8
electronic publication date
display
2021 Dec 9
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34895479
immutable id
pubmed:34895479@c2ce193b8d6b2d8b10ba310dfc5bf06313ea15bc3790a474af701dc472865964
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
1
name
The Lancet. Oncology
nlm unique id
100957246
pages
125-137
volume
23
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2022 Jan;23(1):11-13. doi: 10.1016/S1470-2045(21)00544-1.
    note
    Source null
    related pmid
    34895480
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2022 Feb;23(2):e59. doi: 10.1016/S1470-2045(22)00029-8.
    note
    Source null
    related pmid
    35114129
    relationship
    Erratum in
  3. citation
    Strahlenther Onkol. 2022 Jun;198(6):593-594. doi: 10.1007/s00066-022-01923-4.
    note
    Source null
    related pmid
    35364689
    relationship
    Comment in
outcomes validated
false
pmid
34895479
provenance
batch id
3f4d1914d2afe41e9e70
provider
NCBI PubMed ESummary
record sha256
e06fb19ebe2963cb39d6b78ee185b61135550f6574caa61c7c06a97ca3ad3cac
response sha256
0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
retrieved at
2026-09-09T23:48:06.522634+00:00
publication date
display
2022 Jan
precision
month
year
2022
publication types
  1. Comparative Study
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
  6. Equivalence Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34895479/
title
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.

Preserved source evidence · Not medical advice